Being Alive; February 1994
Alexandra Levine, MD
In patients who have relapsed after remission or who have not responded to initial therapy, no effective alternative treatments have been available. However, two extremely promising experimental therapies are now in trial at USC:
- MGBG, which is given by vein every two weeks,
- a continuous infusion of B4-blocked ricin, a monoclonal antibody directed against the lymphoma cells.
Both of these regimens appear very promising, with excellent preliminary results; both regimens are sponsored by the National Cancer Institute with high priority.
For information regarding these, or other on-going protocols for AIDS-lymphoma, please contact J.J. Anderson, at 213.226.7622.
940201
BA940216
Copyright © 1994 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/